✦ LIBER ✦

Efficacy and Safety of IgPro20, a 20% Immunoglobulin for Subcutaneous Administration, in Patients with Primary Immunodeficiency Switching from Intravenous Replacement Therapy

✍ Scribed by Stephen Jolles; Victor Cristea; Volker Wahn; Marianne Debré; Hilary Longhurst; Othmar Zenker; Hans-Hartmut Peter; Michael Borte

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Efficacy and Safety of a New 20% Immunog

✍ John B. Hagan; Mary B. Fasano; Sheldon Spector; Richard L. Wasserman; Isaac Mela 📂 Article 📅 2010 🏛 Springer 🌐 English ⚖ 197 KB

Efficacy and Safety of a New 20% Immunog

✍ Hagan, J.; Fasano, M.B.; Spector, S.; Wasserman, R.L.; Melamed, I.; Rojavin, M.A 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 48 KB

Efficacy and Safety of Hizentra®, a New

✍ Michael Borte; Malgorzata Pac; Margit Serban; Teresa Gonzalez-Quevedo; Bodo Grim 📂 Article 📅 2011 🏛 Springer 🌐 English ⚖ 182 KB

Efficacy and safety of Hizentra® in pati

✍ S. Jolles; E. Bernatowska; J. de Gracia; M. Borte; V. Cristea; H.H. Peter; B.H. 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 506 KB

Efficacy and safety of home-based subcut

✍ M. Borte; E. Bernatowska; H. D. Ochs; C. M. Roifman; the Vivaglobin Study Group 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 253 KB

Efficacy and Safety of Subcutaneous Viva

✍ Michael Borte; Isabella Quinti; Annarosa Soresina; Eduardo Fernández-Cruz; Bruce 📂 Article 📅 2011 🏛 Springer 🌐 English ⚖ 261 KB